Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Uses  



1.1  Epoxy uses  





1.2  Medical uses  







2 Society and culture  



2.1  Controversies  







3 Production  





4 Coordination chemistry  





5 References  














Triethylenetetramine






تۆرکجه
Cymraeg
Deutsch
Español
فارسی
Français
Italiano
Nederlands

Polski
Română
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Українська

 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 

(Redirected from Trientine)

Triethylenetetramine
Skeletal formula of triethylenetetramine
Ball and stick model of triethylenetetramine
Spacefill model of triethylenetetramine
Names
Preferred IUPAC name

N1,N1-(Ethane-1,2-diyl)di(ethane-1,2-diamine)

Other names
  • N,N'-Bis(2-aminoethyl)ethane-1,2-diamine
  • TETA
  • trien
  • trientine (INN)
  • trientine dihydrochloride
  • MK-0681
  • Identifiers

    CAS Number

  • hydrochloride: 38260-01-4
  • 3D model (JSmol)

    Beilstein Reference

    605448
    ChEBI
  • hydrochloride: CHEBI:9706
  • ChEMBL
  • hydrochloride: ChEMBL3989777
  • ChemSpider
  • hydrochloride: 64521
  • DrugBank
    ECHA InfoCard 100.003.591 Edit this at Wikidata
    EC Number
    • 203-950-6

    Gmelin Reference

    27008
    KEGG
  • hydrochloride: D11649
  • MeSH Trientine

    PubChem CID

  • hydrochloride: 71433
  • RTECS number
    • YE6650000
    UNII
  • hydrochloride: HC3NX54582
  • UN number 2259

    CompTox Dashboard (EPA)

    • InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2 checkY

      Key: VILCJCGEZXAXTO-UHFFFAOYSA-N checkY

    • NCCNCCNCCN

    Properties

    Chemical formula

    C6H18N4
    Molar mass 146.238 g·mol−1
    Appearance Colorless liquid
    Odor Fishy, ammoniacal
    Density 982 mg mL−1
    Melting point −34.6 °C; −30.4 °F; 238.5 K
    Boiling point 266.6 °C; 511.8 °F; 539.7 K

    Solubility in water

    Miscible
    log P 1.985
    Vapor pressure <1 Pa (at 20 °C)

    Refractive index (nD)

    1.496
    Thermochemistry

    Heat capacity (C)

    376 J K−1 mol−1 (at 60 °C)
    Hazards
    GHS labelling:

    Pictograms

    GHS05: Corrosive GHS07: Exclamation mark

    Signal word

    Danger

    Hazard statements

    H312, H314, H317, H412

    Precautionary statements

    P273, P280, P305+P351+P338, P310
    Flash point 129 °C (264 °F; 402 K)
    Lethal dose or concentration (LD, LC):

    LD50 (median dose)

    • 550 mg kg−1 (dermal, rabbit)
  • 2.5 g kg−1 (oral, rat)
  • Pharmacology
    Legal status
    Related compounds

    Related amines

  • Diethylenetriamine
  • Cyclam
  • Related compounds

    Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

    checkY verify (what is checkY☒N ?)

    Infobox references

    Triethylenetetramine (TETA and trien), also known as trientine (INN) when used medically, is an organic compound with the formula [CH2NHCH2CH2NH2]2. The pure freebase is a colorless oily liquid, but, like many amines, older samples assume a yellowish color due to impurities resulting from air-oxidation. It is soluble in polar solvents. The branched isomer tris(2-aminoethyl)amine and piperazine derivatives may also be present in commercial samples of TETA.[3] The hydrochloride salts are used medically as a treatment for copper toxicity.

    Uses

    [edit]

    Epoxy uses

    [edit]

    The reactivity and uses of TETA are similar to those for the related polyamines ethylenediamine and diethylenetriamine. It is primarily used as a crosslinker ("hardener") in epoxy curing.[4][5] TETA, like other aliphatic amines, react quicker and at lower temperatures than aromatic amines due to less negative steric effects since the linear nature of the molecule provides it the ability to rotate and twist.

    Medical uses

    [edit]
    Trientine
    Clinical data
    Trade namesSyprine, Cuprior, Cufence, others
    AHFS/Drugs.comMonograph
    License data
    Pregnancy
    category
  • Routes of
    administration
    By mouth
    ATC code
    Legal status
    Legal status
  • CA: ℞-only[8]
  • UK: POM (Prescription only)[9][10]
  • US: ℞-only[11][12][13]
  • EU: Rx-only[14][15]
  • Identifiers
    • (2-aminoethyl)({2-[(2-aminoethyl)amino]ethyl})amine

    DrugBank
  • DBSALT001269
  • PDB ligand
    CompTox Dashboard (EPA)
    ECHA InfoCard100.003.591 Edit this at Wikidata

    The hydrochloride salt of TETA, referred to as trientine hydrochloride, is a chelating agent that is used to bind and remove copper in the body to treat Wilson's disease, particularly in those who are intolerant to penicillamine.[11] Some recommend trientine as first-line treatment, but experience with penicillamine is more extensive.[16]

    Trientine hydrochloride (brand name Syprine) was approved for medical use in the United States in November 1985.[11]

    Trientine tetrahydrochloride (brand name Cuprior) was approved for medical use in the European Union in September 2017.[14] It is indicated for the treatment of Wilson's disease in adults, adolescents and children five years of age or older who are intolerant to D-penicillamine therapy.[14]

    Trientine dihydrochloride (brand name Cufence) was approved for medical use in the European Union in July 2019.[15] It is indicated for the treatment of Wilson's disease in adults, adolescents and children five years of age or older who are intolerant to D-penicillamine therapy.[15]

    The most common side effects include nausea, especially when starting treatment, skin rash, duodenitis (inflammation of the duodenum, the part of the gut leading out of the stomach), and severe colitis (inflammation in the large bowel causing pain and diarrhea).[15]

    Society and culture

    [edit]

    Controversies

    [edit]

    In the United States, Valeant Pharmaceuticals International raised the price of its Syprine brand of TETA from $625 to $21,267 for 100 pills over five years.[17] The New York Times said that this "egregious" price increase caused public outrage.[17] Teva Pharmaceuticals developed a generic, which patients and doctors expected to be cheaper, but when it was introduced in February 2018, Teva's price was $18,375 for 100 pills.[17] Aaron Kesselheim, who studies drug pricing at Harvard Medical School, said that drug companies price the product at what they think the market will bear.[17]

    Production

    [edit]

    TETA is prepared by heating ethylenediamine or ethanolamine/ammonia mixtures over an oxide catalyst. This process gives a variety of amines, especially ethylene amines which are separated by distillation and sublimation.[4][18]

    Coordination chemistry

    [edit]

    TETA is a tetradentate ligandincoordination chemistry, where it is referred to as trien.[19] Octahedral complexes of the type M(trien)L2 can adopt several diastereomeric structures.[20]

    References

    [edit]
    1. ^ "Health product highlights 2021: Annexes of products approved in 2021". Health Canada. 3 August 2022. Retrieved 25 March 2024.
  • ^ "Regulatory Decision Summary for Waymade-Trientine". Health Canada. 20 April 2021. Retrieved 25 March 2024.
  • ^ "Ethyleneamines" (PDF). Huntsman. 2007. Archived from the original (PDF) on 2019-03-06. Retrieved 2016-07-10.
  • ^ a b Eller K, Henkes E, Rossbacher R, Höke H (2005). "Amines, Aliphatic". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a02_001. ISBN 3527306730.
  • ^ "Triethylenetetramine". webbook.nist.gov. Retrieved 2022-07-20.
  • ^ a b "Trientine Waymade". Therapeutic Goods Administration (TGA). 25 January 2021. Retrieved 8 September 2021.
  • ^ a b "AusPAR: Trientine dihydrochloride". Therapeutic Goods Administration (TGA). 3 May 2021. Retrieved 8 September 2021.
  • ^ "Summary Basis of Decision (SBD) for Mar-Trientine". Health Canada. 23 October 2014. Retrieved 29 May 2022.
  • ^ "Cuprior 150 mg film-coated tablets - Summary of Product Characteristics (SmPC)". (emc). Retrieved 21 September 2020.
  • ^ "Trientine dihydrochloride Tillomed 250 mg capsules, hard - Summary of Product Characteristics (SmPC)". (emc). Retrieved 21 September 2020.
  • ^ a b c "Syprine- trientine hydrochloride capsule". DailyMed. 22 December 2016. Retrieved 21 September 2020.
  • ^ "Trientine hydrochloride capsule". DailyMed. 28 February 2020. Retrieved 21 September 2020.
  • ^ "Cuvrior- trientine tetrahydrochloride tablet, film coated". DailyMed. 20 May 2022. Retrieved 21 January 2023.
  • ^ a b c "Cuprior EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 21 September 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  • ^ a b c d "Cufence EPAR". European Medicines Agency (EMA). 24 May 2019. Retrieved 21 September 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  • ^ Roberts EA, Schilsky ML (June 2003). "A practice guideline on Wilson disease" (pdf). Hepatology. 37 (6): 1475–92. doi:10.1053/jhep.2003.50252. PMID 12774027. S2CID 263620.[dead link]
  • ^ a b c d Thomas K (23 February 2018). "Patients Eagerly Awaited a Generic Drug. Then They Saw the Price". The New York Times. Retrieved 21 September 2020.
  • ^ Brydson JA (1999). "Epoxide Resins". In Brydson JA (ed.). Plastics Materials (Seventh ed.). Oxford: Butterworth-Heinemann. pp. 744–777. doi:10.1016/B978-075064132-6/50067-X. ISBN 9780750641326.
  • ^ von Zelewsky A (1995). Stereochemistry of Coordination Compounds. Chichester: John Wiley. ISBN 047195599X.
  • ^ Utsuno S, Sakai Y, Yoshikawa Y, Yamatera H (1985). "Three Isomers of the Trans -Diammine-[N,N′-bis(2-Aminoethyl)-1,2-Ethanediamine]-Cobalt(III) Complex Cation". Three Isomers of the trans-Diammine-[N,N′-bis(2-Aminoethyl)-1,2-Ethanediamine]-Cobalt(III) Complex Cation. Inorganic Syntheses. Vol. 23. pp. 79–82. doi:10.1002/9780470132548.ch16. ISBN 9780470132548.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Triethylenetetramine&oldid=1234794314"

    Categories: 
    Ethyleneamines
    Chelating agents
    Orphan drugs
    Tetradentate ligands
    Secondary amines
    Hidden categories: 
    All articles with dead external links
    Articles with dead external links from February 2019
    Chemical articles with multiple compound IDs
    Chemicals using indexlabels
    Chemical articles with multiple CAS registry numbers
    Chemical articles with multiple PubChem CIDs
    Chemical articles with multiple ChEBIs
    Articles without InChI source
    ECHA InfoCard ID from Wikidata
    Chembox having GHS data
    Articles containing unverified chemical infoboxes
    Chembox image size set
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Infobox drug articles with non-default infobox title
    Infobox drug articles without a structure image
    Chemical articles without CAS registry number
    Articles without EBI source
    Chemical pages without ChemSpiderID
    Articles without KEGG source
    Articles without UNII source
    Multiple chemicals in Infobox drug
    Multiple chemicals in an infobox that need indexing
    Multiple Chemboxes
     



    This page was last edited on 16 July 2024, at 05:14 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki